Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2000
02/17/2000WO2000008139A1 Tumor necrosis factor-gamma
02/17/2000WO2000008133A1 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE
02/17/2000WO2000008053A1 Novel g-protein coupled receptor protein and dna thereof
02/17/2000WO2000008043A2 Prevention and treatment of viral disease
02/17/2000WO2000007631A1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
02/17/2000WO2000007626A1 Use of anti-coagulation factor antibodies as long-lasting protective agents
02/17/2000WO2000007624A2 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
02/17/2000WO2000007545A2 Apoptosis proteins
02/17/2000WO2000001815A3 Neurotrophic factors
02/17/2000WO1999064583A3 Compositions and methods for modulating proteolytic degradation of intracellular targets
02/17/2000WO1999062932A3 INHIBITION OF VIRAL INFECTION AND SPREAD WITH VIRAL AND RhoA-DERIVED PEPTIDES
02/17/2000WO1999061601A3 Aav5 vector and uses thereof
02/17/2000WO1999058675A3 Human genes and gene expression products v
02/17/2000WO1999057241A9 Myelin basic protein peptides and uses thereof
02/17/2000WO1999055859A3 Cd40-interacting and traf-interacting proteins
02/17/2000WO1999053036A9 Ste20-related protein kinases
02/17/2000WO1999050461A9 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
02/17/2000WO1999045955A9 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS
02/17/2000WO1998029442A9 ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES
02/17/2000DE19836615A1 Preparation of antibody composition useful for purifying components of biological fluids comprises immunizing animals with native and denatured protein fractions
02/17/2000CA2347906A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
02/17/2000CA2347656A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer
02/17/2000CA2339891A1 Chp polypeptide, a ligand of pak65
02/17/2000CA2339352A1 N-acetylglycosaminyltransferase genes
02/17/2000CA2339347A1 Novel g protein-coupled receptor cdna sequence
02/17/2000CA2339322A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses
02/17/2000CA2339086A1 Dna replication- and repair-associated proteins
02/17/2000CA2338983A1 Prevention and treatment of viral disease
02/17/2000CA2338385A1 Human receptor-associated proteins
02/17/2000CA2337980A1 Method to alter the fatty acid metabolism in plants
02/17/2000CA2337861A1 A plant disease resistance signalling gene: materials and methods relating thereto
02/17/2000CA2337741A1 Pancreatic and ovarian polypeptide, zsig58
02/17/2000CA2335648A1 A novel g protein-coupled receptor protein and its dna
02/17/2000CA2305680A1 Death associated kinase containing ankyrin repeats (dakar)
02/17/2000CA2305308A1 Human cdnas encoding polypeptides having kinase functions
02/16/2000EP0979871A1 NOVEL dlg FAMILY MOLECULE, POLYNUCLEOTIDE ENCODING THE SAME, ANTIBODY AGAINST THE SAME, AND METHOD FOR DETECTING dlg GENE
02/16/2000EP0979870A1 Human Wnt-6 polypeptide
02/16/2000EP0979830A1 A novel class of xylanase inhibitors
02/16/2000EP0979410A1 Method for determining cytokine receptor activation by the use of an antibody
02/16/2000EP0979295A1 Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance
02/16/2000EP0979292A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
02/16/2000EP0979289A1 Human lysophospholipase
02/16/2000EP0979288A2 Diagnosis and treatment of phosphatase- or kinase-related disorders
02/16/2000EP0979282A1 Rat st38.2 chemokine
02/16/2000EP0979281A2 A method for making multispecific antibodies having heteromultimeric and common components
02/16/2000EP0979280A1 Polynucleotides encoding a cd53-like transmembrane protein
02/16/2000EP0979277A1 Novel human tumour suppressor gene
02/16/2000EP0979275A1 Novel human mago nashi protein
02/16/2000EP0979274A2 Human p24 vesicle proteins
02/16/2000EP0979246A2 Man monoclonal antibodies to epidermal growth factor receptor
02/16/2000EP0979122A1 Targeted therapy to a biomedical device
02/16/2000EP0979102A1 Polyalkylene oxide-modified single chain polypeptides
02/16/2000CN1244921A Treatment and diagnosis of cancer
02/16/2000CN1244896A Non-M, non-O, HIV-1 strains, fragments and applications
02/16/2000CN1244895A Carrot anti-freeze polypeptides
02/16/2000CN1244873A Antibodies that bind to the nidogen-binding domain of laminin, their production and use
02/16/2000CN1244807A Improved vacines
02/16/2000CN1244805A Stable lyophilized pharmaceutical substance from monoclonal or polyclonal antibodies
02/16/2000CN1244803A Soluble CTLA4 mutant molecules and uses thereof
02/16/2000CN1244772A Targeted cytotoxic cell
02/16/2000CN1049356C Protein-containing aqueous solutions
02/15/2000US6025484 Protein D--an IgD-binding protein ofhaemophilus influenzae
02/15/2000US6025481 Methods of treating cancer using lewis b antigen specific antibodies
02/15/2000US6025477 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
02/15/2000US6025476 Method of detecting fibrinogen; diagnostic methods for determining information associated with atherogenesis and/or thrombogenesis, as well as for determining information associated with pregnancy status or outcome
02/15/2000US6025474 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
02/15/2000US6025473 Nucleic acid which encodes a protein which can confer multidrug resistance on a drug sensitive mammalian cell when expressed in the cell and which is overexpressed in certain multidrug resistant cancer cell lines
02/15/2000US6025469 Murine UCP3 polypeptides
02/15/2000US6025465 Insulin-like growth factor binding protein (IGFBP-6)
02/15/2000US6025333 Treatment of CNS tumors with metalloprotease inhibitors
02/15/2000US6025204 Diagnostic method for detection of placental-derived prostate growth factors
02/15/2000US6025197 Secreted salivary zsig32 polypeptides
02/15/2000US6025196 Chimeric proteins comprising liver enriched transcription factors and nucleic acids encoding the same
02/15/2000US6025180 Asp1
02/15/2000US6025176 For diagnosis and monitoring of insulin dependent diabetes mellitis; antidiabetic agents
02/15/2000US6025166 Human trk receptors and neurotrophic factor inhibitors
02/15/2000US6025165 Producing single-chain molecules of the binding portions of variable regions of light and heavy chains joined by peptide linker, dissociating then reassociating the molecules, separating out and recovering multivalent proteins
02/15/2000US6025163 DNA coding for a peptide of a papilloma virus main capside protein and use thereof
02/15/2000US6025162 Nucleic acid encoding an amino acid sequence of protein; for diagnosis and treatment of allergies
02/15/2000US6025158 Nucleic acids encoding humanized anti-IL-8 monoclonal antibodies
02/15/2000US6025156 Amino acid sequence; for discovery of antibiotics, bactericides, bacteristats against staphylococcus infections
02/15/2000US6025148 Specifically reactive with the alpha e subunit; for diagnostic information relating to atherogenesis and/or thrombogenesis and pregnancy status or outcome
02/15/2000US6025145 Sensitive, reliable immunoassay using eukaryotic cells expressing receptor construct comprising flag polypeptide and tyrosine kinase receptor, exposing to ligand, lysing cells and measuring phosphotyrosine
02/15/2000US6025144 Immunoassay test kit for measuring bone resorption
02/15/2000US6025143 Purified monoclonal or polyclonal antibody against a peptide having specific amino acid sequence from a gene controlled by andogens and isolated from submaxillary gland of the rat; for diagnosis, detection and therapeutics
02/15/2000US6025142 Hydrophobic u-PAR binding site
02/15/2000US6025130 Nucleotide sequence of gene; for screening of homozygotes, diagnosis, and prenatal screening using oligonucleotide primers
02/15/2000US6024964 Membrane anchor/active compound conjugate, its preparation and its uses
02/15/2000US6024957 Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same
02/15/2000US6024956 Interleukins and antiinflammatrory agents
02/15/2000US6024955 Peptide with amino acid sequences
02/15/2000US6024936 Antibody-based method of localizing activated thrombin receptors
02/15/2000CA2189941C Fluorescence polarization detection of nucleic acids
02/15/2000CA2093667C Mouse monoclonal antibodies and uses thereof
02/15/2000CA2005300C Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
02/15/2000CA2004478C Monoclonal antibodies to feline-t-lymphotropic lentivirus
02/15/2000CA1340899C Procede de preparation de complexes nitruro 99m tc, 186 re ou 188 re utilisables comme produits radiopharmaceutiques
02/15/2000CA1340898C Monoclonal antibodies against lymphoma-associated antigens, hybrid cell lines producing these antibodies, and use therefore
02/12/2000CA2248989A1 Novel compounds
02/10/2000WO2000006772A1 Mutations in and genomic structure of herg - a long qt syndrome gene